PHYSICIANS HEALTH SERVICES INC
10-Q, 1997-11-13
HEALTH SERVICES
Previous: TEXTAINER EQUIPMENT INCOME FUND III L P, 10-Q, 1997-11-13
Next: INTRANET SOLUTIONS INC, 10QSB, 1997-11-13



<PAGE>
 
- -------------------------------------------------------------------------------
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                    FORM 10-Q


(Mark One)

[X]     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
        EXCHANGE ACT OF 1934
        For the quarterly period ended September 30, 1997.

[_]     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
        EXCHANGE ACT OF 1934
        For the transition period from ____________ to ____________.


Commission file number 0-21098.


                        Physicians Health Services, Inc.
             (Exact name of registrant as specified in its charter)

               Delaware                                      06-1116976
    (State or other jurisdiction of                        (IRS Employer
     incorporation or organization)                      Identification No.)

         One Far Mill Crossing                                  06484
          Shelton, Connecticut                                (Zip Code)
  (Address of principal executive offices)

        Registrant's telephone number, including area code (203) 381-6400

                                 120 Hawley Lane
                           Trumbull, Connecticut 06611
                ________________________________________________
              (Former name, former address and former fiscal year,
                          if changed since last report)

Indicate by a check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes X No __

There were 6,163,054 shares of Class A Common Stock ($0.01 par value) and
3,185,671 shares of Class B Common Stock ($0.01 par value outstanding as of
November 11, 1997.


- --------------------------------------------------------------------------------
<PAGE>
 
                PHYSICIANS HEALTH SERVICES, INC. AND SUBSIDIARIES

                                TABLE OF CONTENTS


                                                                        PAGE NO.
                                                                        --------
PART I.        Financial Information
               ----------------------

Item 1. Financial Statements

         Condensed Consolidated Balance Sheets at
           September 30, 1997 and December 31, 1996                        3

         Condensed Consolidated Statements of Operations for the 
           Three and Nine Months Ended September 30, 1997 and 1996         4

         Condensed Consolidated Statements of Stockholders' Equity
           for the Nine Months Ended September 30, 1997 and 1996           5

         Condensed Consolidated Statements of Cash Flows for the
           Nine Months Ended September 30, 1997 and 1996                   6

         Notes to Condensed Consolidated Financial Statements          7 - 8

Item 2. Management's Discussion and Analysis of
        Financial Condition and Results of Operations                 9 - 11


PART II.       Other Information
               ------------------
Item 6. Exhibits and Reports on Form 8-K                                  12

        Signatures                                                        13

        Exhibit Index                                                     14
<PAGE>

               PHYSICIANS HEALTH SERVICES, INC. AND SUBSIDIARIES
                     CONDENSED CONSOLIDATED BALANCE SHEETS
                (DOLLARS IN THOUSANDS EXCEPT PER SHARE AMOUNTS)


<TABLE> 
<CAPTION> 
                                                                                   September 30,      December 31,
                                                                                        1997              1996
                                                                                   ------------       ------------
                                                                                    (Unaudited)
<S>                                                                                <C>                <C>  
Assets:

Current Assets
  Cash and Cash Equivalents                                                          $  14,144        $  39,213
  Fixed Maturity Securities, Available for Sale-(amortized cost--1997--$84,468                    
    and 1996--$58,643)                                                                  85,339           59,115
  Accounts Receivable Less Allowances (1997--$1,787 and 1996--$1,781)                   45,546           37,152
  Other Receivables                                                                     58,688           32,157
  Advances to Participating Hospitals                                                       51              400
  Prepaid Expenses and Other                                                               843            1,154
                                                                                     ---------        ---------
    Total Current Assets                                                               204,611          169,191
Property, Plant, and Equipment                                                                    
  Land                                                                                   8,822            8,822
  Building and Improvements                                                             28,724           26,938
  Furniture and Equipment                                                               54,248           46,559
                                                                                     ---------        ---------
                                                                                        91,794           82,319
  Less Accumulated Depreciation and Amortization                                        19,524           15,273
                                                                                     ---------        ---------
    Total Property, Plant, and Equipment                                                72,270           67,046
                                                                                     ---------        ---------
Other Assets (including restricted investments)                                         14,295           13,658
                                                                                     ---------        ---------
Total Assets                                                                         $ 291,176        $ 249,895
                                                                                     =========        =========
                                                                                                  
Liabilities and Stockholders' Equity:                                                             
                                                                                                  
Current Liabilities                                                                               
  Accrued Health Care Expenses                                                       $  74,489        $  51,757
  Unearned Premiums                                                                     29,253           27,757
  Amounts Due to IPA's, Physicians and other Providers                                  53,852           59,084
  Accounts Payable and Accrued Expenses                                                 32,042           13,849
                                                                                     ---------        ---------
    Total Current Liabilities                                                          189,636          152,447
                                                                                                  
Excess of Net Assets Over Cost of Company Acquired                                       1,071            1,162
                                                                                                  
Stockholders' Equity                                                                              
  Class A Common Stock, Par Value $0.01 per Share--Authorized                               59               56
    13,000,000 Shares, Issued and Outstanding; 1997--5,887,454                                    
    shares; 1996--5,566,023 shares                                                                
  Class B Common Stock, Par Value $0.01 per Share;                                          35               38
    Non-transferable--Authorized and Issued 1997--3,532,671 shares;                               
    1996--3,829,880 shares; Voting Rights - 10 per share                                          
  Additional Paid-In Capital                                                            41,886           41,360
  Net Unrealized Gains (Losses) on Fixed Maturity Securities Available for Sale,                  
    Net of Tax                                                                             534              279
  Retained Earnings                                                                     57,956           54,554
                                                                                     ---------        ---------
                                                                                       100,470           96,287
  Less Cost of Class B Common Stock (86,400) Shares in Treasury                              1                1
                                                                                     ---------        ---------
Total Stockholders' Equity                                                             100,469           96,286
                                                                                     ---------        ---------
Total Liabilities and Stockholders' Equity                                           $ 291,176        $ 249,895
                                                                                     =========        =========
</TABLE> 

See Notes to Condensed Consolidated Financial Statements.

                                      -3-
<PAGE>

               PHYSICIANS HEALTH SERVICES, INC. AND SUBSIDIARIES
                CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                    (IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
                                  (Unaudited)


<TABLE> 
<CAPTION> 
                                                                Three Months Ended      Nine Months Ended
                                                                   September 30,          September 30,
                                                               -------------------     -------------------
                                                                 1997       1996         1997       1996
                                                               -------------------     -------------------
<S>                                                            <C>        <C>          <C>        <C> 
REVENUES:
  Premiums                                                     $177,289   $123,190     $488,714   $353,442
  Investment and Other Income                                     2,150      1,545        5,872      4,806
                                                               --------   --------     --------   --------
                                                                179,439    124,735      494,586    358,248

COSTS AND EXPENSES:
  Hospital Services                                              67,904     46,649      172,299    130,435
  Physicians and Related Health Care Services                    67,297     52,726      195,461    143,284
  Other Health Care Services                                     16,912     10,336       49,301     30,486
  Indemnity Costs                                                     -          -            -      7,008
                                                               --------   --------     --------   --------
     Total Health Care Costs                                    152,113    109,711      417,061    311,213
                                                               --------   --------     --------   --------

  Selling, General and Administrative Expenses                   24,756     23,196       72,126     62,934
                                                               --------   --------     --------   --------
                                                                176,869    132,907      489,187    374,147
                                                               --------   --------     --------   --------

  Interest Expense                                                    -        295            -        295

Income (Loss) before Income Taxes                                 2,570     (8,467)       5,399    (16,194)
Income Tax Expense (Benefit)                                        951     (3,931)       1,997     (7,519)
                                                               --------   --------     --------   --------

NET INCOME (LOSS)                                              $  1,619   $ (4,536)    $  3,402   $ (8,675)
                                                               ========   ========     ========   ========

Net Income (Loss) Per Common Share                             $   0.17   $  (0.49)    $   0.36   $  (0.93)
                                                               ========   ========     ========   ========

Weighted Average Number of Common and Common
  Equivalent Shares Outstanding                                   9,588      9,306        9,482      9,298
                                                               ========   ========     ========   ========
</TABLE> 


See Notes to Condensed Consolidated Financial Statements.

                                      -4-
<PAGE>

               PHYSICIANS HEALTH SERVICES, INC. AND SUBSIDIARIES
           CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
                                (IN THOUSANDS)
                                  (Unaudited)


<TABLE> 
<CAPTION> 
                                                                  Nine Months Ended
                                                                    September 30,
                                                             -------------------------
                                                               1997             1996
                                                             -------------------------
<S>                                                          <C>              <C> 
Class A Common Stock
   Balance at Beginning of Period                            $     56         $     53
   Conversion of Class B Common Stock                                     
     into Class A Common Stock                                      3                2
                                                             --------         --------
   Balance at End of Period                                  $     59         $     55
                                                             ========         ========
                                                                          
Class B Common Stock                                                      
   Balance at Beginning of Period                            $     38         $     41
   Conversion of Class B Common Stock                                     
     into Class A Common Stock                                     (3)              (2)
                                                             --------         --------
   Balance at End of Period                                  $     35         $     39
                                                             ========         ========
                                                                          
Additional Paid-In Capital                                                
   Balance at Beginning of Period                            $ 41,360         $ 40,760
   Exercise of Stock Options                                      526              600
                                                             --------         --------
   Balance at End of Period                                  $ 41,886         $ 41,360
                                                             ========         ========
                                                                          
Net Unrealized Gains (Losses)on Fixed Maturity Securities,                
   Net of Tax                                                             
   Balance at Beginning of Period                            $    279         $    510
   Unrealized Appreciation (Depreciation)                         255             (492)
                                                             --------         --------
   Balance at End of Period                                  $    534         $     18
                                                             ========         ========
                                                                          
Retained Earnings                                                         
   Balance at Beginning of Period                            $ 54,554         $ 67,518
   Net Income  (Loss)                                           3,402           (8,675)
                                                             --------         --------
   Balance at End of Period                                  $ 57,956         $ 58,843
                                                             ========         ========
                                                                          
Treasury Stock                                                            
                                                             --------         --------
   Balance at Beginning and End of Period                         ($1)             ($1)
                                                             ========         ========
                                                                          
Total Stockholders' Equity                                                
   Balance at Beginning of Period                            $ 96,286         $108,881
   Exercise of Stock Options                                      526              600
   Net Income (Loss)                                            3,402           (8,675)
   Net Unrealized Appreciation (Depreciation) on                          
       Fixed Maturity Securities                                  255             (492)
                                                             --------         --------
   Balance at End of Period                                  $100,469         $100,314
                                                             ========         ========
</TABLE> 

See Notes to Condensed Consolidated Financial Statements.


                                      -5-
<PAGE>
               PHYSICIANS HEALTH SERVICES, INC. AND SUBSIDIARIES
                CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
                                (IN THOUSANDS)
                                  (Unaudited)

<TABLE> 
<CAPTION> 
                                                                                  Nine Months Ended
                                                                                     September 30,
                                                                                ----------------------
                                                                                  1997         1996
                                                                                ----------------------
<S>                                                                             <C>          <C> 
Operating Activities
Net Income (Loss)                                                               $   3,402    $  (8,675)
Adjustments to Reconcile Net Income to Net Cash
  Provided by (Used for) Operating Activities:
  Depreciation and Amortization                                                     4,280        3,011
  Provision for Doubtful Accounts                                                     492        1,035
  Amortization of Excess of Net Assets over Cost
    of Company Acquired                                                               (91)         (90)
  Deferred Income Tax Expense (Benefit)                                             2,700            -
  Changes in Assets and Liabilities:
       Accounts Receivable                                                          6,057       (7,930)
       Other Receivables                                                          (41,474)     (13,300)
       Advances to Participating Hospitals                                            349        4,649
       Prepaid Expenses and Other                                                     311         (979)
       Accrued Health Care Expenses                                                22,732       15,304
       Unearned Premiums                                                            1,496        1,743
       Due to IPA's, Physicians and Other Providers                                (5,232)       5,585
       Accounts Payable and Accrued Expenses                                       15,350       (7,802)
                                                                                ---------    ---------
Net Cash Provided by (Used for) Operating Activities                               10,372       (7,449)

Investing Activities
  Purchases of Property, Plant, and Equipment                                      (9,527)     (29,642)
  Proceeds from Disposal of Equipment                                                  23           16
  Increase in Other Assets                                                           (637)        (953)
  Purchases of Fixed Maturity Securities                                         (281,117)    (186,802)
  Proceeds from Sales and Maturities of Fixed Maturity Securities                 255,291      205,759
                                                                                ---------    ---------
Net Cash Used for Investing Activities                                            (35,967)     (11,622)

Financing Activities
  Proceeds from Revolving Credit Line                                                   -       18,000
  Exercise of Stock Options                                                           526          600
                                                                                ---------    ---------
Net Cash Provided by Financing Activities                                             526       18,600
                                                                                ---------    ---------

Decrease in Cash and Cash Equivalents                                             (25,069)        (471)
Cash and Cash Equivalents at Beginning of Period                                   39,213        7,536
                                                                                ---------    ---------
Cash and Cash Equivalents at End of Period                                      $  14,144    $   7,065
                                                                                =========    =========
</TABLE> 

See Notes to Condensed Consolidated Financial Statements.

                                      -6-
<PAGE>
 
                PHYSICIANS HEALTH SERVICES, INC. AND SUBSIDIARIES

              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

                               September 30, 1997
                                   (unaudited)




1.  Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been
prepared in accordance with generally accepted accounting principles for interim
financial information and with the instructions to Form 10-Q and Article 10 of
Regulation S-X. Accordingly, they do not include all of the information and
footnotes required by generally accepted accounting principles for complete
financial statements. In the opinion of management, all adjustments (consisting
solely of normal recurring accruals) considered necessary for a fair
presentation have been included. Operating results for the nine month period
ended September 30, 1997 are not necessarily indicative of the results that may
be expected for the year ended December 31, 1997. For further information, refer
to the consolidated financial statements and footnotes thereto included in the
Physicians Health Services, Inc. and Subsidiaries Annual Report on Form 10-K for
the year ended December 31, 1996.


2.  Stockholders' Equity and Per Share Data

Pursuant to the Company's Certificate of Incorporation, upon conversion of Class
B shares to Class A shares, such Class B shares are canceled and cannot be
reissued. Per share data are based upon the weighted average number of common
and common equivalent shares outstanding during the period. Common stock
equivalents are excluded to the extent they have an antidilutive effect on per
share data.

In February 1997, the Financial Accounting Standards Board issued Statement No.
128, Earnings per Share, which is required to be adopted on December 31, 1997.
At that time, the Company will be required to change the method currently used
to compute earnings per share and to restate all prior periods. Under the new
requirements for calculating primary earnings per share, the dilutive effect of
stock options will be excluded. The impact of Statement 128 on the calculation
of primary and fully diluted earnings per share for the quarter and nine months
ended September 30, 1997 and September 30, 1996 is not expected to be material.


3.  New Accounting Pronouncements

In June 1997, the FASB issued Statement of Financial Accounting Standards No.
130, "Reporting Comprehensive Income" ("SFAS 130") and Statement of Financial
Accounting Standards No. 131, "Disclosure about Segments of an Enterprise and
Related Information," ("SFAS 131"). SFAS 130 establishes standards for the
reporting and display of comprehensive income and its components in a full set
of general-purpose financial statements. Comprehensive income is defined as the
change in equity during the financial reporting period of a business enterprise
resulting from non-owner sources. SFAS 131 establishes standards for the
reporting of operating segment information in both annual financial reports and
interim financial reports issued to shareholders. An operating segment is a
component of an entity for which separate financial information is available and
is evaluated regularly by the entity's chief operating management. Both
Statements are effective for fiscal years beginning after December 15, 1997 and
are not expected to have a material impact on the Company.

                                      -7-
<PAGE>
 
                PHYSICIANS HEALTH SERVICES, INC. AND SUBSIDIARIES

              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

                               September 30, 1997
                                   (unaudited)



4.  Tax Provision

The Company is currently under examination by the Internal Revenue Service (IRS)
for certain prior tax years. Management does not expect any proposed adjustments
which may result from the IRS' audit to have a material adverse impact on the
Company's financial position or results of operations.

The Company's effective tax rate is lower than the statutory rate due primarily
to tax exempt interest generated from much of the Company's investment
portfolio.


5.  Reclassifications

Certain reclassifications were made to conform the 1996 amounts to current
presentations in 1997.


6.  Non-monetary Exchange

On May 2, 1997, the Company acquired 200 shares of Physicians Health Services of
New Jersey, Inc. ("PHS NJ") from MasterCare Companies, Inc. ("MasterCare"). In
exchange for the receipt of the shares of PHS NJ the Company gave up 1,250,000
shares of Series B Convertible Preferred Stock of MasterCare Companies, Inc. and
190 shares of Common Stock of MasterCare of Connecticut, Inc. Since the common
stock of MasterCare and PHS NJ are not publicly traded, fair values of the
shares exchanged were estimated. MasterCare shares were valued based on prices
obtained in a recent private placement while the fair value of PHS NJ shares
were derived from a valuation of membership. The purchase price paid (fair value
of MasterCare's shares held by the Company) exceeded the fair value of
MasterCare's proportionate interest in the net assets of PHS NJ acquired from
MasterCare by approximately $1.8 million. Such excess will be amortized over 10
years. As a result of this transaction, PHS NJ became a wholly-owned subsidiary
of the Company. This transaction resulted in a net gain of $348 thousand which
is reflected in selling, general and administrative expenses.


7.  Merger Agreement

On May 8, 1997, the Company and Foundation Health Systems, Inc. ("FHS") executed
a merger agreement pursuant to which FHS would acquire all of the shares of
common stock of the Company for $29.25 per share in cash, or a total
consideration to the Company's stockholders of approximately $280 million. On
October 19, 1997, the Company and FHS agreed to a new acquisition price of
$28.25 per share in cash or a total consideration of approximately $271 million
and eliminated as a condition of the consummation of the merger the obtaining of
certain waivers and consents from The Guardian Life Insurance Company of
America ("The Guardian") in connection with the Company's joint marketing
arrangements with The Guardian. Should the Company obtain such waivers and
consents prior to consumation of the merger, the price would return to $29.25
per share. FHS announced that it intends to finance the purchase with a
combination of cash and bank debt. As part of the transaction, the Company has
entered into a voting trust agreement with the Greater Bridgeport Individual
Practice Association ("GBIPA"), which owns shares constituting approximately 61%
of the voting power of the Company. The agreement stipulates that such shares
will be voted in favor of the transaction by GBIPA. The transaction is subject
to certain closing conditions, including receipt of regulatory approvals.

                                      -8-
<PAGE>
 
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
        AND RESULT OF OPERATIONS


Results of Operations
- ---------------------

Quarter Ended September 30, 1997 Versus September 30, 1996
Nine Months Ended September 30, 1997 Versus September 30, 1996

Premium revenue increased 43.9% to $177.3 million in the third quarter of 1997
from $123.2 million for the comparable 1996 quarter. For the nine months ended
September 30, 1997, premium revenue increased 38.3% to $488.7 million from
$353.4 million for the comparable 1996 period. Enrollment at September 30,1997
was 496,502, an increase of 39.7% from enrollment of 355,402 at September 30,
1996. As of September 30, 1997, fully insured enrollees increased 49.5% to
426,152 members up from 285,059 members as of September 30, 1996, while self-
funded enrollees remained essentially unchanged at 70,350 members as of
September 30, 1997. The aggregate premium revenue increase lagged the fully
insured membership growth due primarily to the growth of membership in the
Healthcare Solutions product where 50% of all the premium revenue and related
health care costs related to this business for 1997 are ceded to The Guardian
pursuant to reinsurance agreements with the Company's subsidiaries. Until
October 1, 1996, the Healthcare Solutions activity in Connecticut was reported
under a profit sharing arrangement. According to the provisions of the profit
sharing arrangement, the Company recorded 100% of the premium revenue from
Connecticut Healthcare Solutions activity until October 1, 1996. After October
1, 1996, the profit sharing agreement was replaced by the reinsurance agreement
as in effect for 1997. The effect was to reduce the percentage premium increase
as compared to what such increase would have been if the reinsurance agreement
had been in effect throughout 1996. This effect was offset by an increase in
revenue from Medicare products resulting from a shift in membership from cost to
risk products which carry higher revenue yields and an increase in the pricing
of some of the commercial products.

Investment and other income increased 39.2% to $2.2 million for the third
quarter of 1997 from $1.5 million for the third quarter of 1996. On a year-to-
date basis, investment and other income increased 22.2% to $5.9 million from
$4.8 million for the nine months ended September 30, 1996. The increase is due
primarily to an increase in investable assets.

Health care expenses as a percentage of premium revenues (medical loss ratio)
declined to 86.6% for the third quarter of 1997 as compared to 90.3% for the
third quarter of 1996. For the nine months ended September 30, 1997, the medical
loss ratio was 86.2% down from 89.4% for the first nine months of 1996. Total
health care expenses increased 38.6% to $152.1 million in the third quarter of
1997 from $109.7 million for the comparable 1996 quarter. On a year-to-date
basis, total health care expenses increased 34.0% to $417.1 million for the
first nine months of 1997 from $311.2 million for the same 1996 period. The
improvement in the medical loss ratios for both the quarter and year-to-date
periods is the result of an increase in fully insured revenue that exceeded the
rise in total medical expenses.

Hospital services expenses increased 45.6% to $67.9 million in the third quarter
of 1997 from $46.7 million for the third quarter of 1996. Hospital services
expenses for the first nine months of 1997 totaled $172.3 million up 32.1% from
$130.4 million in the first nine months of 1996. The rise in hospital services
expenses was due, in part, to the 49.5% increase in fully insured enrollees.
Additionally, an overall reduction in commercial hospital rates for both
inpatient and outpatient services was somewhat mitigated by a new claims
assessment in New York from the implementation of the Hospital Care Reform Act
of 1996 ("HCRA"), which became effective on January 1, 1997. The New York State
legislature enacted HCRA, which requires the Company to make payments to state
funding pools to finance hospital bad debt and charity care, graduate medical
education, and other state programs. The claims assessment under HCRA is equal
to 8.18% of qualified New York hospital costs and is expected to continue to
increase the Company's hospital costs in the future.

                                      -9-
<PAGE>
 
Results of Operations (con't)
- -----------------------------

Commercial inpatient utilization for the third quarter of 1997 decreased 8.4%
from the third quarter of 1996 with commercial bed days per thousand members at
251 days for the third quarter of 1997 versus 274 days for the same 1996 period.
On a year-to-date basis, commercial bed days per thousand members decreased 6.5%
from 277 days per thousand members for the nine months ended September 30, 1996
to 259 days per thousand members for the nine months ended September 30, 1997.
The improvement in the commercial product line was offset by a 182% and 138%
increase in the per member per month hospital expenses for government products
for the quarter and nine months ended September 30, 1997, respectively. The
increase is primarily due to the introduction of the Medicare risk products and
the resulting shift in membership from the Medicare cost product (for which the
Company does not carry full risk on hospital services) to the Medicare risk
products for which the Company carries substantially more of the hospital risk.
The Company expects hospital costs for the Medicare products to continue to rise
as membership (and related revenue) in this product increases.

Physician and related health care expenses increased by 27.6% from $52.7 million
for the third quarter of 1996 to $67.3 million for the third quarter of 1997.
For the nine months ended September 30, 1997, physician and related health care
expenses increased 36.4% to $195.5 million from $143.3 million for the same 1996
period. The increase in physician and related health care expenses is primarily
due to the increase in fully insured membership and increases in certain
non-capitated services. Additionally, the introduction of the Medicare risk
products have contributed to the rise in physician costs.

Other health care expenses increased by $6.6 million or 63.6% in the third
quarter of 1997 and by $18.8 million or 61.7% on a year-to-date basis. The
increase is primarily due to the increase in fully insured membership and due to
the inclusion of the covered lives assessment in New York as a result of HCRA.
This assessment is expected to continue to increase other health care expenses
in the future. Additionally, prescription drug expenses continue to increase
across all product lines.

Indemnity costs reflect the medical costs associated with the indemnity revenue
assumed in connection with The Guardian reinsurance arrangement in New York
under which the Company shared risk for indemnity business with The Guardian
until June 30, 1996.

Selling, general and administrative expenses increased 6.7% or $1.6 million in
the third quarter of 1997 from the comparable 1996 period. For the nine months
ended September 30, 1997, selling, general and administrative expenses rose
14.6% or $9.2 million over the prior year. The increase is due primarily to
increased personnel and facilities expenses needed to support the enrollment
growth and product diversity. The increase was partially offset by increases in
the recovery of operating expenses from The Guardian under the terms of the
reinsurance agreements related to the Healthcare Solutions product. The selling,
general and administrative expenses as a percentage of premium revenues improved
to 14.0% for the third quarter of 1997 down from 18.8% for the third quarter of
1996. On a year-to-date basis, selling, general and administrative expenses as a
percentage of premium revenues totaled 14.8% down from 17.8% for the comparable
1996 period.


Liquidity and Capital Resources
- -------------------------------
PHS has historically financed its operations primarily through internally
generated funds. The Company's primary capital requirements are for working
capital, principally to fund geographic and product expansion, and to maintain
necessary regulatory capital. The Company's HMO and insurance subsidiaries are
subject to statutory regulations that restrict the payment of dividends.

Cash and cash equivalents decreased $25.1 million to $14.1 million at September
30, 1997 from $39.2 million at December 31, 1996. 

                                      -10-
<PAGE>
 
Liquidity and Capital Resources
- -------------------------------

Cash provided by operations increased primarily due to a combination of growth
in business, a return to profitability, and timing of claims payments and other
disbursements in the ordinary cause of business. Cash provided by operations
also includes a federal tax refund related to prior tax years.

The Company expects to require additional capital, over the next several years,
principally for computer and technology system enhancements and to maintain
necessary regulatory capital. The Company's spending on the computer and
technology system enhancements has been temporarily suspended pending the
merger. Therefore, the additional capital requirements may be less than
originally estimated. If the system enhancements are reinstated, the capital
requirements will be restored and could be in excess of amounts originally
anticipated. The Company believes that in addition to its current capital
resources and internally generated funds, it will be able to obtain financing,
if necessary, sufficient for its continued operations, although it can provide
no assurances in this regard.

"Management's Discussion and Analysis of Financial Condition and Results of
Operations" includes certain forward looking statements (including statements
identified by the use of such words as "expects", "believes" or similar
expressions). Actual results could differ materially from those discussed.
Additional information concerning factors that could cause actual results to
differ materially from those in forward looking statements is contained in Item
7 of the Company's Annual Report on Form 10-K for the fiscal year ended December
31, 1996 under the caption "Cautionary Statement".

                                      -11-
<PAGE>
 
                                     PART II

                                OTHER INFORMATION


ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K
         ---------------------------------

        (a)  Exhibit Number       Description of Exhibit
             --------------       ----------------------

                  27              Financial data schedule




        (b)  Reports on Form 8-K

        There were no reports filed on Form 8-K for the quarter ended September 
        30, 1997.

                                      -12-
<PAGE>
 
                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                        Physicians Health Services, Inc.
                        --------------------------------
                                  (Registrant)



Date:   November 13, 1997                          /s/ James L. Elrod, Jr.
        ------------------------------             -----------------------------
                                                       James L. Elrod, Jr.
                                                       Chief Financial Officer



Date:   November 13, 1997                          /s/ Robert L. Natt
        ------------------------------             -----------------------------
                                                       Robert L. Natt
                                                       President

                                      -13-
<PAGE>
 
                                  EXHIBIT INDEX



        Exhibit Number                               Description of Exhibit
        --------------                               ----------------------
                27                                   Financial data schedule.

                                      -14-

<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                           14144
<SECURITIES>                                     85339
<RECEIVABLES>                                    45546
<ALLOWANCES>                                      1787
<INVENTORY>                                          0
<CURRENT-ASSETS>                                204611
<PP&E>                                           91794
<DEPRECIATION>                                   19524
<TOTAL-ASSETS>                                  291176
<CURRENT-LIABILITIES>                           189636
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            59
<OTHER-SE>                                      100410
<TOTAL-LIABILITY-AND-EQUITY>                    291176
<SALES>                                         488714
<TOTAL-REVENUES>                                494586
<CGS>                                           417061
<TOTAL-COSTS>                                   417061
<OTHER-EXPENSES>                                 72126
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                   5399
<INCOME-TAX>                                      1997
<INCOME-CONTINUING>                               3402
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      3402
<EPS-PRIMARY>                                      .36
<EPS-DILUTED>                                      .36
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission